CA2385884A1 - 26 proteines secretees humaines - Google Patents

26 proteines secretees humaines Download PDF

Info

Publication number
CA2385884A1
CA2385884A1 CA002385884A CA2385884A CA2385884A1 CA 2385884 A1 CA2385884 A1 CA 2385884A1 CA 002385884 A CA002385884 A CA 002385884A CA 2385884 A CA2385884 A CA 2385884A CA 2385884 A1 CA2385884 A1 CA 2385884A1
Authority
CA
Canada
Prior art keywords
seq
polypeptide
human
sequence
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002385884A
Other languages
English (en)
Inventor
George A. Komatsoulis
Steven M. Ruben
Craig A. Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2385884A1 publication Critical patent/CA2385884A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne de nouvelles protéines sécrétées humaines et des acides nucléiques isolés contenant les régions codantes des gènes codant ces protéines. L'invention se rapporte également à des vecteurs, des cellules hôtes, des anticorps, et à des techniques de recombinaison permettant de produire les protéines sécrétées humaines précitées. L'invention concerne en outre des procédés diagnostiques et thérapeutiques utilisés pour diagnostiquer et traiter des maladies, des troubles et/ou des états liés aux nouvelles protéines sécrétées humaines de l'invention.
CA002385884A 1999-09-27 2000-09-26 26 proteines secretees humaines Abandoned CA2385884A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15580699P 1999-09-27 1999-09-27
US60/155,806 1999-09-27
PCT/US2000/026337 WO2001023547A1 (fr) 1999-09-27 2000-09-26 26 proteines secretees humaines

Publications (1)

Publication Number Publication Date
CA2385884A1 true CA2385884A1 (fr) 2001-04-05

Family

ID=22556873

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002385884A Abandoned CA2385884A1 (fr) 1999-09-27 2000-09-26 26 proteines secretees humaines

Country Status (5)

Country Link
EP (1) EP1220901A1 (fr)
JP (1) JP2003510074A (fr)
AU (1) AU7714400A (fr)
CA (1) CA2385884A1 (fr)
WO (1) WO2001023547A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US20030166522A1 (en) * 2000-12-12 2003-09-04 Ketchum Karen A. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002062998A1 (fr) * 2001-02-06 2002-08-15 Takeda Chemical Industries, Ltd. Nouvelle proteine et son adn
WO2002099093A2 (fr) * 2001-06-01 2002-12-12 Bayer Aktiengesellschaft Regulation de l'enzyme humaine hydroxymethyl-glutaryl-coa de type lyase
US20030044933A1 (en) * 2001-08-15 2003-03-06 Millennium Pharmaceuticals, Inc. 96895, a human sodium-hydrogen exchanger family member and uses therefor
WO2006063462A1 (fr) 2004-12-13 2006-06-22 Alethia Biotherapeutics Inc. Sequences polynucleotidiques et polypeptidiques participant au remodelage osseux

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753446A (en) * 1993-04-15 1998-05-19 National Jewish Center For Immunology & Respiratory Medicine Mitogen ERK kinase kinase (MEKK) assay
AU3602097A (en) * 1996-07-15 1998-02-09 Regents Of The University Of California, The Genes from 20q13 amplicon and their uses

Also Published As

Publication number Publication date
WO2001023547A1 (fr) 2001-04-05
EP1220901A1 (fr) 2002-07-10
AU7714400A (en) 2001-04-30
JP2003510074A (ja) 2003-03-18

Similar Documents

Publication Publication Date Title
US20050239099A1 (en) 27 human secreted proteins
WO2001021658A1 (fr) 32 proteines humaines secretees
US6936691B2 (en) Secreted protein HCE3C63
EP1234030A2 (fr) 18 proteines secretees humaines
WO2001032910A2 (fr) 27 proteines humaines secretees
CA2389722A1 (fr) 15 proteines secretees humaines
US7078186B2 (en) Apoptosis related polynucleotides, polypeptides, and antibodies
CA2390438A1 (fr) Nouvelles proteines 19 secretees par l'homme
CA2384264A1 (fr) Polynucleotides recepteurs de proteine tyrosine kinase (ptk), polypeptides et anticorps ptk
US20030036646A1 (en) Uncoupling protein polynucleotides, polypeptides, and antibodies
US20050010042A1 (en) 26 human secreted proteins
CA2398275A1 (fr) Polynucleotides, polypeptides et anticorps humains
CA2382729A1 (fr) 29 proteines associees au cancer humain
US20070172830A1 (en) Antibodies to hhpen62 polypeptide
CA2385884A1 (fr) 26 proteines secretees humaines
CA2389305A1 (fr) 28 proteines secretees humaines
CA2390421A1 (fr) 24 proteines humaines secretees
CA2397502A1 (fr) Polynucleotides de serine/threonine-phosphatases, polypeptides et anticorps
EP1220865A1 (fr) 43 proteines secretees humaines
CA2384584A1 (fr) 38 proteines secretees humaines
EP1235844A1 (fr) 28 proteines humaines secretees
CA2387754A1 (fr) 10 proteines humaines secretees
WO2001034767A2 (fr) 22 proteines humaines secretees
US20060099575A9 (en) 67 human secreted proteins
CA2395815A1 (fr) Acides nucleiques, proteines et anticorps

Legal Events

Date Code Title Description
FZDE Dead